As of January 23, 2025, Senti Biosciences (SNTI) has a market cap of $20.970 million USD. According to our data, Senti Biosciences is ranked No.8592 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $20.97 M |
30.20%
|
Dec 31, 2024 | $16.11 M |
-46.82%
|
Dec 29, 2023 | $30.29 M |
-53.19%
|
Dec 30, 2022 | $64.70 M |
-85.70%
|
Dec 31, 2021 | $0.45 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
USA
|
Verve Therapeutics
VERV
|
$0.66 B |
0.000 M
|
USA
|
Market Cap | = | SNTI Stock Price | * | SNTI Shares Outstanding |
= | $4.57 | * | 4.59 M | |
= | $20.97 M |